InspireMD, Inc. (NSPR)
0.80
-0.03
(-3.63%)
USD |
NASDAQ |
Sep 09, 12:42
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 37.54M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -65.41% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 5.983 |
| Price to Book Value | 1.191 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.096 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 100.00% |
Profile
| InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL. |
| URL | http://www.inspiremd.com |
| Investor Relations URL | http://www.inspiremd.com/en/investors/investor-relations/ |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Value |
| Next Earnings Release | Nov. 10, 2026 (est.) |
| Last Earnings Release | Aug. 17, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL. |
| URL | http://www.inspiremd.com |
| Investor Relations URL | http://www.inspiremd.com/en/investors/investor-relations/ |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Value |
| Next Earnings Release | Nov. 10, 2026 (est.) |
| Last Earnings Release | Aug. 17, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |